Requires Authorization

Concordance of two polymerase chain reaction–based blood group genotyping platforms for patients with sickle cell disease

C.A. Sheppard

C.A. Sheppard

Gold Standard Laboratory Consulting Group, LLC, and Department of Pathology, University of VirginiaCharlottesville, Virginia
Search for this author on
Sciendo|Google Scholar
Sheppard, C.A.
, 
N.L. Bolen

N.L. Bolen

Immunohematology Reference Laboratory, ITxM DiagnosticsRichmond, VA
Search for this author on
Sciendo|Google Scholar
Bolen, N.L.
, 
G. Meny

G. Meny

Medical Affairs Diagnostic, Grifols Diagnostic SolutionsSan Marcos, TX
Search for this author on
Sciendo|Google Scholar
Meny, G.
, 
M. Kalvelage

M. Kalvelage

LifeShare Blood CenterShreveport, Louisiana
Search for this author on
Sciendo|Google Scholar
Kalvelage, M.
 and 
G. Ochoa-Garay

G. Ochoa-Garay

Immunohematology Center, Grifols Diagnostic SolutionsSan Marcos, TX
Search for this author on
Sciendo|Google Scholar
Ochoa-Garay, G.
  
Jan 01, 2020
Concordance of two polymerase chain reaction–based blood group genotyping platforms for patients with sickle cell disease's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: article
Published Online: Jan 01, 2020
Page range: 123 - 128
DOI: https://doi.org/10.21307/immunohematology-2020-050
Keywords
© 2020 C.A. Sheppard et al., published by Sciendo
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Laboratory Medicine
Journal RSS Feed